Last update:

Laboratory medicine news

Single blood protein stands out among 30 tests for assessing fatty liver disease

The reliable assessment of metabolic dysfunction-associated steatotic liver disease (MASLD) is crucial for determining the stage of the disease, initiating appropriate treatments and monitoring the course of therapy. To date, ...

Spinal fluid DNA testing may clarify brain tumor diagnoses when MRI leaves questions

A Mayo Clinic study published in the Journal of Neuro-Oncology suggests that analyzing DNA in cerebrospinal fluid could provide another source of information when MRI cannot provide a clear brain tumor diagnosis or obtaining ...

Novel blood test detects lung cancer traces long before scans

Despite advances in early-stage lung cancer treatment, a significant number of patients experience disease recurrence after surgery or initial therapy. A study has now demonstrated that a blood test (liquid biopsy) can reliably ...

A simple blood test could reveal hidden radiation exposure

Scientists at Lawrence Berkeley National Laboratory (Berkeley Lab) have developed a machine learning tool that can detect and estimate past radiation exposure using the information in a standard complete blood count, or CBC, ...

Q&A: Expert discusses Russian plague scare

The reported death of 28-year-old laboratory technician Darya Shipilova at the Irkutsk Research Anti-Plague Institute in Shelekhov, Siberia, Russia, has raised questions about a possible exposure to pneumonic plague and prompted ...

Routine blood test may suggest future dementia risk

A common blood test already carried out during routine health checks may contain clues about a person's long-term risk of dementia, according to research being presented at the ECNP Congress in Munich and published in the ...

A new AI tool distinguishes Ewing sarcoma from similar tumors

A team from the Universitat Politècnica de València (UPV) and the University of Valencia (UV) has developed and validated an artificial intelligence (AI) system capable of distinguishing Ewing sarcoma from other morphologically ...

Improving the diagnosis of primary aldosteronism

A simple new method based on the results of two studies from Christofer Juhlin's research group can make it easier to identify the underlying cause of a common form of high blood pressure and help predict who will benefit ...

Blood test may help guide treatment for metastatic melanoma

A blood test that measures how quickly tumor cells divide could in the future help doctors assess prognosis and select treatment strategies for patients with melanoma that has spread to other parts of the body. This is shown ...

ULTRA maps glioma margins in 3D within 30 minutes

One of the major challenges in glioma surgery is that tumor boundaries are often difficult to define. Diffuse gliomas can infiltrate surrounding brain tissue beyond what surgeons can see directly or what conventional imaging ...

AI maps tumor cells that may seed later metastases

A cancerous tumor is not a single enemy. It is made up of many different cell populations that can behave in very different ways. Among them, even at the time of diagnosis, there may already be cells that months or years ...

Single blood test could provide more information about cancer

A single blood test could in the future provide a more comprehensive picture of cancer than current methods. In a review article published in the journal Genome Medicine, researchers at Karolinska Institutet describe how ...

Simple blood test on a chip could help diagnose lung cancer

Researchers at Tel Aviv University have developed a new method for diagnosing lung cancer: a simple, fast, low-cost blood test that does not require DNA sequencing. The method identifies a chemical fingerprint of cancer cells ...

AI model maps tumor tissue to improve cancer care

A tumor is more than its cancer cells. Immune cells, blood vessels and other surrounding tissue influence how a cancer grows and responds to treatment. Two tumors containing the same cell types can respond very differently ...

Blood marker tracks hidden progression in multiple sclerosis

Modern therapies have transformed care for people with multiple sclerosis (MS). Yet the disease continues to progress in a substantial proportion of patients, even in the absence of relapses. Detecting and treating this gradual ...